test
tripl
drug
combin
experi
ribavirin
standard
care
summar
tabl
addit
effect
observ
effect
dose
use
tripl
combin
effect
combin
hcv
inhibitor
z
tertbutoxycarbonylamino
cyclopropylsulfonylcarbamoyl
e
pyrrolo
summar
tabl
ec
higher
experi
sinc
combin
perform
genotyp
replicon
cell
result
two
experi
indic
mix
additivitysynergi
methylsulfonamido
alloster
inhibitor
target
palm
site
ii
polymeras
test
combin
overal
result
three
experi
indic
mix
additivitysynergi
tabl
also
test
combin
hydroxymethyl
pyrimidinon
nucleosid
analog
three
experi
synergyaddit
observ
three
ratio
effect
level
tabl
result
three
experi
indic
mix
synergyaddit
result
demonstr
combin
treatment
replicon
cell
ribavirin
inhibitor
target
hcv
proteas
polymeras
yield
addit
synergist
antivir
effect
importantli
neither
antagon
antivir
activ
enhanc
cytotox
observ
combin
abil
use
combin
therapi
provid
major
advantag
singl
drug
therapi
treatment
hcv
hcv
genom
display
restrict
tissu
host
tropism
date
effici
replic
genotyp
replicon
cell
cultur
adapt
mutat
mainli
observ
human
hepatoma
cell
line
ensur
inhibit
hcv
replic
inhibitor
artifact
cell
line
potenc
evalu
transient
replicon
assay
use
genotyp
replicon
whose
replic
requir
adapt
mutat
hela
hek
cell
hcv
proteas
inhibitor
use
posit
control
shown
tabl
potenc
similar
cell
type
ec
valu
rang
pm
suggest
function
inhibit
highli
conserv
differ
cell
environ
subject
select
studi
includ
men
women
age
year
inclus
chronic
infect
hcv
genotyp
treatment
naiv
subject
treatment
nonrespond
defin
subject
receiv
current
standard
care
interferon
andor
ribavirin
continu
detect
hcv
rna
level
includ
relaps
subject
attain
log
declin
hcv
rna
level
week
stop
treatment
treatmentintoler
subject
defin
subject
unabl
toler
toxic
associ
interferon
andor
ribavirin
receiv
anoth
replic
cofactor
inhibitor
coinfect
hiv
hbv
hcv
genotyp
elig
subject
also
hcv
rna
viral
load
iuml
document
score
aspart
aminotransferas
ast
platelet
ratio
index
apri
bodi
mass
index
bmi
kgm
inclus
subject
sign
inform
consent
form
screen
determin
elig
base
medic
histori
physic
examin
measur
vital
sign
ecg
clinic
laboratori
measur
includ
serolog
code
region
amplifi
genotyp
specif
primer
select
list
tabl
ggttggcctcgatgaggtcagcg
gccgaaggtctttgtggcgagc
tcctccgcagcgcatggcgtg
tgtggacgccttcgccttcatctc
tggtgtcaattggtgtctcagtgt
gcttgcggcctcctttctctgg
ccatagggcttttctttgatttc
genotyp
analysi
perform
popul
sequenc
provid
hcv
rna
level
iuml
determin
emerg
viral
variant
follow
administr
singl
dose
total
rna
isol
viral
sequenc
amplifi
serum
sampl
collect
hcvinfect
subject
three
cohort
mg
popul
sequenc
result
sampl
deriv
baselin
hour
postdos
summar
tabl
rna
chang
timepoint
rel
baselin
present
variant
detect
gener
note
solvent
obtain
commerci
sourc
use
without
dri
andor
purif
start
materi
either
purchas
commerci
sourc
prepar
accord
note
literatur
protocol
hnmr
spectra
record
use
bruker
mhz
instrument
cnmr
spectra
record
use
bruker
mhz
instrument
chemic
shift
assign
ppm
rel
respect
solvent
signal
eg
signal
residu
chcl
present
cdcl
hnmr
follow
abbrevi
use
describ
signal
split
pattern
singlet
doublet
triplet
quartet
q
multiplet
broad
br
med
chem
mg
mmol
thiourea
mg
mmol
dissolv
absolut
etoh
ml
naoac
g
mmol
ad
mixtur
heat
hr
cool
solvent
partial
remov
rotari
evapor
volum
dilut
etoac
vol
wash
h
aqueou
layer
extract
et
combin
organ
layer
wash
brine
concentr
crude
product
subject
chromatographi
silica
gel
elut
etoachexan
afford
azid
yellow
oil
mg
j
cf
hz
j
cf
hz
mh
calcd
c
h
found
mixtur
ketoamid
g
mmol
nh
oac
g
mmol
xylen
ml
heat
seal
tube
hr
volatil
compon
remov
vacuo
residu
partit
care
etoac
h
satur
nahco
solut
ad
care
stir
ph
aqueou
phase
slightli
basic
layer
separ
aqueou
layer
extract
etoac
combin
organ
phase
wash
brine
dri
mgso
filter
concentr
vacuo
result
materi
recrystal
etoachexan
provid
two
crop
imidazol
dens
light
yellow
solid
g
mother
liquor
concentr
vacuo
subject
flash
chromatographi
silica
gel
etoachexan
eluant
provid
addit
g
imidazol
combin
yield
mmol
ml
reaction
flask
purg
n
cap
heat
oil
bath
hr
reaction
mixtur
filter
filtrat
concentr
vacuo
crude
materi
partit
care
ch
cl
ml
aqueou
medium
compris
ml
h
ml
satur
nahco
solut
aqueou
layer
extract
ch
cl
combin
organ
phase
dri
mgso
filter
concentr
vacuo
result
materi
purifi
use
flash
chromatographi
sampl
load
elut
solvent
etoacch
cl
provid
boron
contamin
pinacol
dens
offwhit
solid
g
rel
mole
ratio
boron
pinacol
accord
hnmr
analysi
sampl
submit
next
phase
extract
meohchcl
ml
combin
organ
phase
wash
brine
dri
mgso
filter
concentr
vacuo
silica
gel
mesh
prepar
result
crude
materi
submit
flash
chromatographi
use
etoac
eluant
afford
biphenyl
contamin
small
amount
ph
po
offwhit
solid
mg
yield
hnmr
mhz
dmsod
ppm
